AFL 📈 Aflac - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0010551028

AFL: Life Insurance, Health Insurance, Cancer Insurance, Disability Insurance

Aflac Incorporated is a leading provider of supplemental health and life insurance products, operating through two primary segments: Aflac Japan and Aflac U.S. The company's extensive range of products is designed to help individuals and families mitigate financial risks associated with unexpected medical expenses, disability, and death. In Japan, Aflac offers a diverse portfolio of insurance products, including cancer, medical, and nursing care insurance, as well as whole and term life insurance, and savings-type insurance products such as WAYS and child endowment plans.

The Aflac U.S. segment provides a broad array of insurance products, including cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care, and disability insurance, in addition to term and whole life insurance. These products are designed to help individuals and families in the United States manage financial risks and protect their assets. Aflac's distribution network is comprised of sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies, allowing the company to effectively reach a wide range of customers.

With a history dating back to 1955, Aflac Incorporated has established itself as a trusted and reliable provider of supplemental insurance products. The company is headquartered in Columbus, Georgia, and its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol AFL. Aflac's website, https://www.aflac.com, provides detailed information on its products, services, and investor relations. The company's ISIN is US0010551028, and it is classified under the GICS Sub Industry of Life & Health Insurance, reflecting its focus on providing essential insurance products to individuals and families.

Additional Sources for AFL Stock

AFL Stock Overview

Market Cap in USD 58,064m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Life & Health Insurance
IPO / Inception 1984-07-19

AFL Stock Ratings

Growth 5y 88.4%
Fundamental 12.2%
Dividend 69.4%
Rel. Strength Industry -9.11
Analysts 3.08/5
Fair Price Momentum 109.27 USD
Fair Price DCF 149.35 USD

AFL Dividends

Dividend Yield 12m 2.51%
Yield on Cost 5y 5.55%
Annual Growth 5y 9.24%
Payout Consistency 95.5%

AFL Growth Ratios

Growth Correlation 3m -51.1%
Growth Correlation 12m 92%
Growth Correlation 5y 97.2%
CAGR 5y 17.12%
CAGR/Mean DD 5y 1.97
Sharpe Ratio 12m 1.12
Alpha 0.74
Beta 1.10
Volatility 28.32%
Current Volume 4847.5k
Average Volume 20d 2273.3k
What is the price of AFL stocks?
As of December 21, 2024, the stock is trading at USD 102.69 with a total of 4,847,500 shares traded.
Over the past week, the price has changed by -1.75%, over one month by -6.85%, over three months by -4.42% and over the past year by +29.96%.
Is Aflac a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Aflac is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 12.19 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AFL as of December 2024 is 109.27. This means that AFL is currently overvalued and has a potential downside of 6.41%.
Is AFL a buy, sell or hold?
Aflac has received a consensus analysts rating of 3.08. Therefor, it is recommend to hold AFL.
  • Strong Buy: 1
  • Buy: 2
  • Hold: 8
  • Sell: 1
  • Strong Sell: 1
What are the forecast for AFL stock price target?
According to ValueRays Forecast Model, AFL Aflac will be worth about 120.2 in December 2025. The stock is currently trading at 102.69. This means that the stock has a potential upside of +17.03%.
Issuer Forecast Upside
Wallstreet Target Price 105.8 3%
Analysts Target Price 77.1 -24.9%
ValueRay Target Price 120.2 17%